Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age

NCT00242424 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1375

Enrollment

OTHER

Sponsor class

Conditions

Inactivated Influenza Vaccine

Interventions

BIOLOGICAL: 2005-2006 trivalent inactivated influenza vaccine

Sponsor

Seattle Children's Hospital

Collaborators

[object Object]